Publication Cover
Natural Product Research
Formerly Natural Product Letters
Volume 26, 2012 - Issue 9
274
Views
12
CrossRef citations to date
0
Altmetric
Research Articles

A new sesquiterpenoid from the rhizomes of Homalomena sagittifolia

, , , , , & show all
Pages 850-858 | Received 29 Jun 2010, Accepted 30 Dec 2010, Published online: 14 Oct 2011
 

Abstract

A new sesquiterpenoid, 1α,4β,7β-eudesmanetriol (1), was isolated together with the known compounds 1β,4β,7β-eudesmanetriol (2) and oplopanone (3) from the rhizomes of Homalomena sagittifolia. The structures of these compounds were determined by extensive spectral analyses. The compounds 1 and 2 inhibited growth of Pseudomonas stutzeri with a MIC value of 117 µM when evaluated for antibacterial activity using the minimum concentration assay. Both these compounds showed remarkable activities against acetylcholinesterase enzyme with IC50 values ranging between 25 and 26 µM. The isolation of these sesquiterpenoids and their biological activities observed in this study support the reported traditional uses of H. sagittifolia for the treatment of microbial related diseases and central nervous system disorders.

Acknowledgements

The authors would like to aknowledge the research grant no. RU1001/PKIMIA/811050 provided by the Universiti Sains Malaysia, Penang. One of us (Abdul Hamid) would like to thank USM for the award of a postgraduate fellowship.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.